Everything below concerns alpha-MSH analog. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Melanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amide | Naming follows peptide convention; the numeral distinguishes it from melanotan-1 |
| Molecular formula | C50H69N15O9 | Includes the lactam bridge; no counter-ion assumed |
| Monoisotopic mass | 1023.53 Da | Free base; salts and counter-ions shift the observed value |
| Appearance | White to off-white lyophilised powder | Batch-to-batch colour variation is not itself proof of impurity |
| Typical analytical method | RP-HPLC purity determination with ESI-MS identity confirmation | Retention time alone does not establish sequence identity |
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Ridomihan Kersus (リドミハ星人カーサス, Ridomiha Seijin Kāsasu): A plant-themed criminal from Planet Ridomiha who is charged with murder and planetary invasion and is capable of secreting healing liquid from her stalks and producing high-powered water streams capable of slicing objects. Due to their homeworld changing from a water-based planet to a desert-based one, she and her sister Karmia (カーミア, Kāmia) scouted Earth with the intention of stealing its water. After Karmia developed second thoughts, Kersus killed her and framed an alien named Braidy, but Sen-Chan discovers the truth before the Dekarangers delete Kersus with the D-Bazooka. Kersus is voiced by Tomoka Hayashi (林 知花, Hayashi Tomoka), who also portrays her human form. Cuwartlian Dazgonelr (クウォータ星人ダゴネール, Kuwōta Seijin Dagonēru): A childish 10,708-year-old octopus-themed Alienizer from Planet Cuwartl who is charged with turning people into dolls. He manipulates Hikaru, a lonely boy with the power to teleport objects, into helping him before he is deleted by Dekaranger Robo while piloting the Kaijuki Embarns (エンバーンズ, Enbānzu). Dazgonelr is voiced by Yasuhiro Takato (高戸 靖広, Takato Yasuhiro). Zamuzan Sheik (ザムザ星人シェイク, Zamuza Seijin Sheiku): A beetle-themed criminal and bomb manufacturer from Planet Zamuza who was arrested on charges of mass-murder via explosives and imprisoned in the Prison Satellite Prisron (監獄衛生プリズロン, Kangoku Eisei Purizuron).
=== Mammals === Bats are not blind. While about 70% of bat species, mainly in the microbat family, use echolocation to navigate, all bat species have eyes and are capable of sight. In addition, almost all bats in the megabat or fruit bat family cannot echolocate and have excellent night vision. Bulls are not enraged by the color red, used in capes by professional bullfighters. Cattle are dichromats, so red does not stand out as a bright color. It is not the color of the cape, but the perceived threat by the bullfighter that incites it to charge, along with the spearing of the bull, mental agitation and abuse it endures beforehand. Camels do not store water in their humps, but rather fatty tissue which can be used as a reserve source of calories. While they can go long periods without water, the water is stored in the animal's bloodstream, not their humps. Domestic cats' behavioral and personality traits cannot be predicted from their coat color. Rather, these traits depend on a complex interplay between genetic and environmental factors. Not all cats are attracted and intoxicated by catnip, which affects only about two thirds of them. Alternatives exist, such as valerian root and leaves. Dogs do not sweat by salivating. Dogs actually do have sweat glands, but not on their tongues; they sweat mainly through their footpads. However, dogs do primarily regulate their body temperature through panting. (See also: Dog anatomy § Temperature regulation) Dogs do not consistently age seven times as quickly as humans.
Increased entry of megakaryocytes into the systemic circulation. Under normal circumstances in healthy individuals, megakaryocytes that arise from the bone marrow are trapped in the pulmonary capillary bed and broken down before entering the systemic circulation. In disorders where there is prominent extrapulmonary shunting of blood (e.g. cyanotic heart diseases, liver cirrhosis), the megakaryocytes can bypass the breakdown within the pulmonary circulation and enter the systemic circulation. They are then trapped within the capillary beds within the extremities, such as the digits, and release PDGF and VEGF. In cases or diffuse pulmonary diseases or lung cancer, the excess VEGF produced in the diseased parts of the lungs directly enter circulation. Hypoxia induces the expression of VEGF by platelets. It also enhances the release of PFGF and VEGF by megakaryocytes. Other causes of platelet and/or endothelial cell activation, including: Overproduction of prostaglandin E by other tissues, such as in lung cancer and Crohn's disease. This is usually linked to higher levels of COX-2. Underconsumption of prostaglandin E by other tissues, such as in HPGD and/or SLCO2A1 mutations (pachydermoperiostosis, see above). Use of prostaglandin E medication. A chronic excess of platelets, such as in inflammatory bowel disease. In thyroid acropachy, the explanation leans autoimmune and probably involves a process similar to thyroid eye disease, with increased proliferation of fibroblasts and deposition of glycosamines.
=== Stereoisomers === Since synephrine exists as either of two enantiomers (see: § Chemistry, below) which do not produce identical biological effects (see: § Pharmacology, below), some researchers have examined the stereoisomeric composition of synephrine extracted from natural sources. Although it seems clear that synephrine is found in those Citrus species which have been studied predominantly as the l-isomer, low levels of d-synephrine have been detected in juice and marmalade made from C. unshiu, and low levels (0.002%) have been reported in fresh fruit from C. aurantium. There are indications that some d-synephrine may be formed by the racemization of l-synephrine as a result of the processing of fresh fruit, although this matter has not been completely clarified. However, regardless of the situation in Citrus species, Ranieri and McLaughlin reported the isolation of racemic (i.e. a mixture of equal amounts of d- and l- stereoisomers) synephrine from a cactus of the genus Dolichothele, under conditions that would be unlikely to cause a significant amount of racemization.
==== Chronic kidney disease ==== While there is no conclusive evidence that a high protein diet can cause chronic kidney disease, there is a consensus that people with this disease should decrease consumption of protein. According to one 2009 review updated in 2018, people with chronic kidney disease who reduce protein consumption have less likelihood of progressing to end stage kidney disease. Moreover, people with this disease while using a low protein diet (0.6 g/kg/d - 0.8 g/kg/d) may develop metabolic compensations that preserve kidney function, although in some people, malnutrition may occur.
Sources: en.wikipedia.org
=== Cyberwarfare and cyber sanctions === In addition to retaliatory digital attacks, countries can respond to cyber attacks with cyber sanctions. Sometimes, it is not easy to detect the attacker, but suspicions may focus on a particular country or group of countries. In these cases, unilateral and multilateral economic sanctions can be used instead of cyberwarfare. For example, the United States has frequently imposed economic sanctions related to cyber attacks. Two Executive Orders issued during the Obama administration, EO 13694 of 2015 and EO 13757 of 2016, specifically focused on the implementation of the cyber sanctions. Subsequent US presidents have issued similar Executive Orders. The US Congress has also imposed cyber sanctions in response to cyberwarfare. For example, the Iran Cyber Sanctions Act of 2016 imposes sanctions on specific individuals responsible for cyber attacks.
Normal human hemoglobins are tetrameric proteins composed of two pairs of globin chains, each of which contains one alpha-like (α) globin and one beta-like (β) globin. Each globin chain is associated with an iron-containing heme moiety. Throughout life, the synthesis of the α and the β chains is balanced so that their ratio is relatively constant and there is no excess of either type. The specific α and β chains that are incorporated into Hb are highly regulated during development:
=== Long-term use === There have been no serious adverse effects reported on long-term use of DMT, apart from acute cardiovascular events. Repeated and one-time administration of DMT produces marked changes in the cardiovascular system, with an increase in systolic and diastolic blood pressure; although the changes were not statistically significant, a robust trend towards significance was observed for systolic blood pressure at high doses.
Narrated by Robin Ellis, produced by Rachel Allen, directed by Sarah Marris, made by TVF Media 24 May Storm in a D Cup, about breast implants; Sally Kirkland was a main protagonist against implants; Sybil Niden Goldrich of the Command Trust Network; Marcia Angell of The New England Journal of Medicine; the British 1990s glamour model Teresa May; Roger Sturrock of the University of Glasgow; Dennis Deapen of the University of Southern California; Sai Ramastry of the University of Illinois Chicago; British 1990s glamour model Hannah Callow sat nonchalantly on a London underground train, with surreptitious nearby male attention. Directed by Martin Durkin (often chose quite controversial topics), made by his company Kugelblitz 7 June Curse of the Phantom Limbs, about sensations of phantom limbs; Jackie Naylor lost her hand in an accident on the A57 in 1989; neuroscientist Peter Halligan, since 2018 the Chief Scientific Adviser for Wales; photographer Alexa Wright makes superfiction images of phantom limbs; the Douglas Bader Centre at the Queen Mary's Hospital, Roehampton; Canadian psychologist Ronald Melzack of McGill University; Conrad Weiskrantz, son of neuroscientist Lawrence Weiskrantz had a motorbike accident on a country road, where he hit a vehicle towing a trailer turning right; the Silver Spring monkeys; neuroscientist V. S. Ramachandran of University of California, San Diego; Canadian neurosurgeon Wilder Penfield conducted cortical stimulation mapping research in the 1950s, resulting in the cortical homunculus and cortical maps; neurosurgeon Tipu Aziz.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.
The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.
No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.